Diabetes & Vascular Disease Research

Papers
(The TQCC of Diabetes & Vascular Disease Research is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature63
Safety of four SGLT2 inhibitors in three chronic diseases: A meta-analysis of large randomized trials of SGLT2 inhibitors39
Baicalin ameliorates atherosclerosis by inhibiting NLRP3 inflammasome in apolipoprotein E-deficient mice26
Role of platelet-derived growth factor in type II diabetes mellitus and its complications22
Epigallocatechin-3-gallate ameliorates glucolipid metabolism and oxidative stress in type 2 diabetic rats21
The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study17
The association between sodium-glucose cotransporter 2 inhibitors and incident dementia: A nationwide population-based longitudinal cohort study16
High myopia is protective against diabetic retinopathy via thinning retinal vein: A report from Fushun Diabetic Retinopathy Cohort Study (FS-DIRECT)14
EP4 signalling is essential for controlling islet inflammation by causing a shift in macrophage polarization in obesity/type 2 diabetes12
Estimated glucose disposal rate demographics and clinical characteristics of young adults with type 1 diabetes mellitus: A cross-sectional pilot study12
High hemoglobin glycation index is associated with increased systemic arterial stiffness independent of hyperglycemia in real-world Japanese population: A cross11
Low levels of circulating anti-ageing hormone Klotho predict the onset and progression of diabetic retinopathy10
Comparative study of microvascular structural changes in the gestational diabetic placenta9
Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques9
Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry9
Impaired subendocardial perfusion in patients with metabolic syndrome8
Triglyceride-glucose index is prospectively associated with chronic kidney disease progression in Type 2 diabetes – mediation by pigment epithelium-derived factor8
Timed physical exercise does not influence circadian rhythms and glucose tolerance in rotating night shift workers: The EuRhythDia study8
Evaluation of the relationship between cardiac autonomic function and glucose variability and HOMA-IR in prediabetes8
Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME®8
Sleep behaviours and associated habits and the progression of pre-diabetes to type 2 diabetes mellitus in adults: A systematic review and meta-analysis7
Impact of insulin therapy on outcomes of diabetic patients with heart failure: A systematic review and meta-analysis7
Accurate prediction of HbA1c by continuous glucose monitoring using a kinetic model with patient-specific parameters for red blood cell lifespan and glucose uptake7
Plasma levels of tissue inhibitor of metalloproteinase-1 in patients with type 1 diabetes mellitus associate with early diabetic neuropathy and nephropathy7
Vascular inflammation, atherosclerosis, and lipid metabolism and the occurrence of non-high albuminuria diabetic kidney disease: A cross-sectional study7
Extracellular vesicles in gestational diabetes mellitus: A scoping review7
Impact of COVID-19 therapy on hyperglycemia7
Use of continuous glucose monitoring trend arrows in the younger population with type 1 diabetes6
Glucolipotoxicity induces endothelial cell dysfunction by activating autophagy and inhibiting autophagic flow6
Hyperinsulinemia alters insulin receptor presentation and internalization in brain microvascular endothelial cells6
SENP3 regulates high glucose-induced endothelial dysfunction via ROS dependent signaling6
Association of triglyceride-glucose with cardiac hemodynamics in type 2 diabetes6
Deteriorated regional calf microcirculation measured by contrast-free MRI in patients with diabetes mellitus and relation with physical activity6
Shared and specific biological signalling pathways for diabetic retinopathy, peripheral neuropathy and nephropathy by high-throughput sequencing analysis6
Risk of orthostatic hypotension associated with sodium-glucose cotransporter-2 inhibitor treatment: A meta-analysis of randomized controlled trials6
Relation of Helicobacter pylori infection to peripheral arterial stiffness and 10-year cardiovascular risk in subjects with diabetes mellitus6
Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis6
Mitochondrial mitophagy protection combining rivaroxaban and aspirin in high glucose-exposed human coronary artery endothelial cell. An in vitro study6
Genetic variation in CARD8, a gene coding for an NLRP3 inflammasome-associated protein, alters the genetic risk for diabetic nephropathy in the context of type 2 diabetes mellitus6
0.045367956161499